☆ 4.2 Article

Targeting Ibrutinib-Resistant BTK-C481S Mutation with ARQ 531, a Reversible Non-Covalent Inhibitor of BTK

Clinical Lymphoma Myeloma & Leukemia (2016)

Journal

Clinical Lymphoma Myeloma & Leukemia

Volume 16, Issue -, Pages S47-S48

Publisher

Elsevier BV

DOI: 10.1016/j.clml.2016.07.068

Keywords

-

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.